Skip to main content
Fig. 3 | BMC Neurology

Fig. 3

From: Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review

Fig. 3

Incidence of reported symptomatic medication use at the baseline visit. Only medication use with an incidence of ≥10 % in any group is reported. *P = 0.04 for 3-way comparison. DMF = dimethyl fumarate; FTY = fingolimod; NSAID = non-steroidal anti-inflammatory drug; TFN = teriflunomide

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us